NOHO, INC. TO CONSOLIDATE OPERATIONS AMID BOOMING ALCOHOL SALES

Rhea-AI Summary

NOHO, Inc. (OTC PINK: DRNK) is finalizing an agreement with a Florida-based supplement manufacturer to streamline production, packaging, and fulfillment of their After Shot product. This strategic move will significantly reduce shipping and operational costs by allowing the product to be packed and shipped from a single FDA-registered facility. The company anticipates launching three new products in 2022. As alcohol consumption rises, NOHO's After Shot is positioned to cater to evolving consumer behaviors and capitalize on new market trends.

Positive

• Transitioning to a Florida-based manufacturer will reduce shipping costs and operational expenses.
• Plans to launch three new products in 2022, beginning with a nootropic formulation.
• The After Shot product is strategically targeting a growing consumer segment due to increased alcohol consumption.

Negative

• None.

Scottsdale, Arizona, Dec. 13, 2021 (GLOBE NEWSWIRE) -- NOHO, Inc. (OTC PINK: DRNK), a Wyoming corporation (the “Company”), announced the following:

The Company is finalizing an agreement with a Florida-based supplement manufacturer to assume production, packaging and fulfillment services from a single location. 

Currently, the After Shot is manufactured and packed in one facility and the full product is shipped to a separate fulfillment center.  Through the new logistics partner, the product will be shipped from the formulator in a concentrate, without water, which reduces shipping costs substantially.  The product will then be finished, bottled and packed in the Florida location, which is an FDA/cGMP registered facility.  Unlike most manufacturers and bottlers, our new logistics partner also has fulfillment capabilities on premises. As a result, the Company will eliminate the entirety of those shipping expenses.  Further, reducing costs, the pick and pack charges incurred with each consumer sale are substantially lower than those of the current provider.  As the Company seeks to launch three new products in 2022, starting with the nootropics, focus formulation, the cost savings achieved with the After Shot will be multiplied across the entire product line.

Alcohol Sales Soar

Since alcohol sales soared in 2020, revenues have remained high into 2021 and new categories have emerged that are poised to sustain growth into the future.

As consumers were confined to their homes for the better part of 2020, the popularized video-streaming drinking parties and amateur at-home barkeeps that emerged, have changed consumer behavior, perhaps for the long-term.  The proliferation of DIY recipes from newly minted celebrity mixologists, combined with surging sales of alcohol-related hardware, has resulted in brands developing products in the new category of Ready-to-Drink (RTD).  Research has also revealed that the increase in sales is from larger individual purchases, suggesting that more of the heaver drinkers may suffer an increase of the dreaded day-after hangover.  The Company’s After Shot is targeted to the heart of these growing market segments.  From the late-twenties junior executive, who still parties hard but now finds it hard to get going the next morning, to the soccer moms having after-game cocktails and the bougie, online drinking-club Winos, NOHO’s After Shot is the remedy for those next day woes.   

NOHO is reacting to the evolving market by developing strategies adapted to the new alcohol consumer and increased consumption from regular drinkers.  In either case, the overall surge in alcohol consumption and revenues is the ideal market environment and timing for NOHO going into the new year.

Eric Stoll, the founder of  Lifetime Branding Collab. and now NOHO’s marketing and branding leader, said, “NOHO’s entry into the recovery space, given the recent massive uptick in drinking behavior, is timed perfectly.  The After Shot is positioned to be completely unapologetic, offering a much-needed hand of natural goodness to the battle-worn partyer suffering the next-day blues.  We don’t care who you are or how you got there, NOHO also stands for NO judgment!  We’re building a brand around fun and the enjoyment of life.”

David Mersky, NOHO’s CEO, said, “The timing couldn’t be better for NOHO going into 2022.  As we unleash Eric on the growing alcohol market, I’m laser focused on our financials and moving toward our planned offering.” 

More from NOHO – In addition to the After Shot, we have developed a new line of products, all leveraging Hydro-Nano technology, which will be rolling out soon.  For additional information and product updates, please follow us at www.nohoshot.com and follow NOHO on Twitter at www.twitter.com/NOHOdrink.   

Cautionary Note Regarding Forward-Looking Statements.

This press release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of Noho, Inc. (the “Company”), its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words “may,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities.

Contact:

IR@TheCampusCo.com

Attachment

• $DRNK - NOHO, Inc.

FAQ

What is the latest news about NOHO, Inc. (DRNK)?

NOHO, Inc. is finalizing an agreement with a supplement manufacturer to streamline production and fulfillment of its After Shot product, which will reduce costs.

How will the new agreement impact NOHO, Inc.'s (DRNK) operations?

The new agreement allows for production and fulfillment from a single location, significantly reducing shipping costs and operational expenses.

What new products is NOHO, Inc. (DRNK) planning to launch in 2022?

NOHO plans to launch three new products in 2022, starting with a nootropic formulation.

How is NOHO, Inc. (DRNK) responding to changes in alcohol consumption trends?

NOHO is positioning its After Shot product to cater to consumers with increased alcohol consumption, tapping into the growing market for recovery solutions.